Sandoz Group (OTCMKTS:SDZNY) Sets New 1-Year High - Here's What Happened

Key Points

• Sandoz Group's share price reached a new 52-week high of $63.72 during mid-day trading, indicating strong market interest.
• Analysts have given a consensus rating of "Hold" on Sandoz Group, with Jefferies Financial Group recently downgrading their rating from "strong-buy" to "hold".
• The company's financial metrics show a debt-to-equity ratio of 0.57 and a current ratio of 1.24, suggesting stable liquidity and manageable debt levels.

Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) hit a new 52-week high during trading on Friday . The company traded as high as $63.72 and last traded at $63.72, with a volume of 369 shares traded. The stock had previously closed at $63.00.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered Sandoz Group from a "strong-buy" rating to a "hold" rating in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of "Hold".

Sandoz Group Price Performance

The company has a 50-day moving average price of $57.97 and a 200-day moving average price of $49.59. The company has a current ratio of 1.24, a quick ratio of 0.79 and a debt-to-equity ratio of 0.57.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.